Digitizing Quality: Trends and Regulatory Challenges in eQMS Adoption in the Pharmaceutical Sector

Abstract

This paper explores the how electronic Quality Management Systems (eQMS) are changing the pharmaceutical industry. The need to improve product quality, operational efficiency, and regulatory compliance drives this change. It discusses the basic benefits of eQMS, such as automation and real-time data access. It also covers new technology trends like Artificial Intelligence, the Internet of Things, cloud computing, and blockchain that are changing quality standards. The paper focuses on the complex global regulatory landscape. It details guidelines from USFDA, EMA, ICH, WHO, PIC/S, MCC/SAHPRA, and ANVISA related to data integrity and computerized system validation. Additionally, it examines how to use and validate common eQMS tools like LIMS, SAP Quality Management, and TrackWise. The paper ends by highlighting the crucial role of thorough software validation and ongoing compliance with changing global guidelines. This ensures the reliability and integrity of digital quality processes, which ultimately protects patient safety and product effectiveness.